Cargando…

Dyslipidemia in Pediatric Type 2 Diabetes Mellitus

PURPOSE OF REVIEW: Cardiovascular (CV) disease is a major cause of mortality in type 2 diabetes mellitus (T2D). Dyslipidemia is prevalent in children with T2D and is a known risk factor for CVD. In this review, we critically examine the epidemiology, pathophysiology, and recommendations for dyslipid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sunil, Bhuvana, Ashraf, Ambika P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Pediatric Type 2 and Monogenic Diabetes (O Pinhas-Hamiel, Section Editor)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481147/ https://www.ncbi.nlm.nih.gov/pubmed/32909078 http://dx.doi.org/10.1007/s11892-020-01336-6

Ejemplares similares

Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease
por: Stols-Gonçalves, Daniela, et al.
Publicado: (2019)

Substitution among milk and yogurt products and the risk of incident type 2 diabetes in the EPIC‐NL cohort
por: Stuber, J. M., et al.
Publicado: (2020)

Dipeptidyl Peptidase-4 Inhibitor Development and Post-authorisation Programme for Vildagliptin — Clinical Evidence for Optimised Management of Chronic Diseases Beyond Type 2 Diabetes
por: Strain, William David, et al.
Publicado: (2017)

Effects of potato resistant starch intake on insulin sensitivity, related metabolic markers and appetite ratings in men and women at risk for type 2 diabetes: a pilot cross‐over randomised controlled trial
por: Sanders, L. M., et al.
Publicado: (2020)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

The Vildagliptin Experience — 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration
por: Foley, James E, et al.
Publicado: (2017)

Clinical Safety and Tolerability of Vildagliptin — Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance
por: Mathieu, Chantal, et al.
Publicado: (2017)

Lifestyle Therapy for the Treatment of Youth with Type 2 Diabetes
por: McGavock, Jonathan, et al.
Publicado: (2014)

Diagnostic Test Accuracy of Urine C-peptide Creatinine Ratio for the Correct Identification of the Type of Diabetes: A Systematic Review
por: Pappachan, Joseph M, et al.
Publicado: (2022)

Novel therapeutic targets and agents for pediatric dyslipidemia
por: Sunil, Bhuvana, et al.
Publicado: (2021)

Genetic Risk of Progression to Type 2 Diabetes and Response to Intensive Lifestyle or Metformin in Prediabetic Women With and Without a History of Gestational Diabetes Mellitus
por: Sullivan, Shannon D., et al.
Publicado: (2014)

Beta-cell Insufficiency
por: Kalra, Sanjay, et al.
Publicado: (2017)

Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
por: Hanefeld, Markolf, et al.
Publicado: (2013)

The Reality of Type 2 Diabetes Prevention
por: Kahn, Richard, et al.
Publicado: (2014)

Diabetes-Specific Nutrition Algorithm: A Transcultural Program to Optimize Diabetes and Prediabetes Care
por: Mechanick, Jeffrey I., et al.
Publicado: (2012)

Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus
por: Ortiz-Martínez, Margarita, et al.
Publicado: (2022)

Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes
por: Lamprea-Montealegre, Julio A., et al.
Publicado: (2018)

Transculturalization of a Diabetes-Specific Nutrition Algorithm: Asian Application
por: Su, Hsiu-Yueh, et al.
Publicado: (2012)

Transcultural Diabetes Nutrition Therapy Algorithm: The Asian Indian Application
por: Joshi, Shashank R., et al.
Publicado: (2012)

A study on pharmacokinetics, pharmacodynamics and safety of lixisenatide in children and adolescents with type 2 diabetes
por: Barrientos‐Pérez, Margarita, et al.
Publicado: (2022)

Household food insecurity is associated with diabetic ketoacidosis but not severe hypoglycemia or glycemic control in youth and young adults with youth‐onset type 2 diabetes
por: Reid, Lauren A., et al.
Publicado: (2022)

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
por: Garvey, W. Timothy, et al.
Publicado: (2014)

Case-Based Insights: Arab Muslim Mothers’ Experiences of Managing a Child Newly Diagnosed With Type 1 Diabetes Mellitus
por: Rossiter, Rachel Cathrine, et al.
Publicado: (2019)

Pathophysiology of Type 2 Diabetes in Children and Adolescents
por: Valaiyapathi, Badhma, et al.
Publicado: (2020)

Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus
por: Bahtiyar, Gül, et al.
Publicado: (2016)

A “Spoonful of Sugar” and the Realities of Diabetes Prevention!
por: Cefalu, William T.
Publicado: (2014)

An Effective Diabetic Ketoacidosis Prevention Intervention in Children With Type 1 Diabetes
por: Vitale, Rebecca J., et al.
Publicado: (2018)

Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401–1408
por: Bress, Adam P., et al.
Publicado: (2018)

β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians
por: Yabe, Daisuke, et al.
Publicado: (2015)

Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes?: Health Be Damned! Pour on the Sugar
por: Bray, George A., et al.
Publicado: (2014)

Management of Type 1 Diabetes in Pregnancy
por: Feldman, Anna Z., et al.
Publicado: (2016)

The Role of Epigenetics in Type 1 Diabetes
por: Jerram, Samuel T., et al.
Publicado: (2017)

Human plasma‐derived alpha(1)‐proteinase inhibitor in patients with new‐onset type 1 diabetes mellitus: A randomized, placebo‐controlled proof‐of‐concept study
por: Lagarde, William H., et al.
Publicado: (2020)

T Cell Receptor Profiling in Type 1 Diabetes
por: Jacobsen, Laura M., et al.
Publicado: (2017)

Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes
por: Poynard, Thierry, et al.
Publicado: (2021)

Type 2 Diabetes: Multiple Genes, Multiple Diseases
por: Udler, Miriam S.
Publicado: (2019)

Type 1 Diabetes at a Crossroads!
por: Cefalu, William T., et al.
Publicado: (2015)

A cross‐sectional study of patients referred for HNF1B‐MODY genetic testing due to cystic kidneys and diabetes
por: Sztromwasser, Paweł, et al.
Publicado: (2020)

Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Al Ghadeer, Hussain A, et al.
Publicado: (2021)

Diabetes Today
por: Weyman, Kate, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hnlbs566sqtdhh2e77i1u9b8fi